<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9007917</journal-id><journal-id journal-id-type="pubmed-jr-id">1045</journal-id><journal-id journal-id-type="nlm-ta">Int J STD AIDS</journal-id><journal-title-group><journal-title>International journal of STD &#x00026; AIDS</journal-title></journal-title-group><issn pub-type="ppub">0956-4624</issn><issn pub-type="epub">1758-1052</issn></journal-meta><article-meta><article-id pub-id-type="pmid">32693739</article-id><article-id pub-id-type="pmc">7530071</article-id><article-id pub-id-type="doi">10.1177/0956462420926344</article-id><article-id pub-id-type="manuscript">HHSPA1619730</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>They are likely to be there: using a family-centered index testing approach to identify children living with HIV in Kenya</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Okoko</surname><given-names>Nicollate</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kulzer</surname><given-names>Jayne L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3314-9891</contrib-id><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ohe</surname><given-names>Kristen</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mburu</surname><given-names>Margaret</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Muttai</surname><given-names>Hellen</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Abuogi</surname><given-names>Lisa L</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Bukusi</surname><given-names>Elizabeth A</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Craig R</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Penner</surname><given-names>Jeremy</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib></contrib-group><aff id="A1"><label>1</label>Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya</aff><aff id="A2"><label>2</label>Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA, USA</aff><aff id="A3"><label>3</label>School of Medicine, University of Colorado, Denver, CO, USA</aff><aff id="A4"><label>4</label>Department of Global Health, University of Washington, Seattle, WA, USA</aff><aff id="A5"><label>5</label>Division of Global HIV/AIDS, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya</aff><aff id="A6"><label>6</label>Department of Pediatrics, University of Colorado, Aurora, CO, USA</aff><aff id="A7"><label>7</label>University of British Columbia, Vancouver, Canada</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Authors&#x02019; contribution</p><p id="P2">The author contributions include: study design: NO, JLK, KO, HM, JP; data analysis: MM; first manuscript draft preparation: NO, JLK, KO, MM, JP; reviewing and revision of the manuscript: all authors; approving the final manuscript draft: all authors.</p></fn><corresp id="CR1"><bold>Corresponding author:</bold> Jayne L Kulzer, 550 16th Street, 3rd Floor, San Francisco, CA 94158, USA. <email>jayne.kulzer@ucsf.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>18</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>10</month><year>2021</year></pub-date><volume>31</volume><issue>11</issue><fpage>1028</fpage><lpage>1033</lpage><!--elocation-id from pubmed: 10.1177/0956462420926344--><permissions><license license-type="permissions-link"><license-p>Article reuse guidelines: <ext-link ext-link-type="uri" xlink:href="https://uk.sagepub.com/en-gb/eur/journals-permissions">sagepub.com/journals-permissions</ext-link></license-p></license></permissions><abstract id="ABS1"><p id="P3">In Kenya, only half of children with a parent living with HIV have been tested for HIV. The effectiveness of family-centered index testing to identify children (0&#x02013;14 years) living with HIV was examined. A retrospective record review was conducted among adult index patients newly enrolled in HIV care between May and July 2015; family testing, results, and linkage to treatment outcomes were followed through May 2016 at 60 high-volume clinics in Kenya. Chi square test compared yield (percentage of HIV tests positive) among children tested through family-centered index testing, outpatient and inpatient testing. Review of 1937 index client charts led to 3005 eligible children identified for testing. Of 2848 (94.8%) children tested through family-centered index testing, 127 (4.5%) had HIV diagnosed, 100 (78.7%) were linked to care, and 85 of those eligible (91.4%) initiated antiretroviral therapy (ART).Family testing resulted in higher yield compared to inpatient (1.8%, p &#x0003c; 0.001) or outpatient testing (1.6%, p &#x0003c; 0.001). The absolute number of children living with HIV identified was highest with outpatient testing. The relative contribution of testing approach to total children identified with HIV was outpatient testing (69%), family testing (26%), and inpatient testing (5%). The family testing approach demonstrated promise in achieving the first two &#x0201c;90s&#x0201d; (identification and ART initiation) of the 90&#x02013;90&#x02013;90 targets for children, with additional effort required to improve linkage from testing to treatment.</p></abstract><kwd-group><kwd>HIV</kwd><kwd>Africa</kwd><kwd>screening</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P4">In Kenya, despite national gains in reducing new HIV infections among children (0&#x02013;14 years) from 18,000 in 2010 to 7600 in 2018, and drastically reducing HIV-related deaths from 16,000 in 2010 to 5200 in 2018,<sup><xref rid="R1" ref-type="bibr">1</xref></sup> a need to identify children living with HIV remains. A national survey in 2012 found that among children 18 months to 14 years old with a parent living with HIV, only 52.9% had been tested for HIV.<sup><xref rid="R2" ref-type="bibr">2</xref></sup></p><p id="P5">Children with undiagnosed HIV often present with severe opportunistic infections and inadequate growth and have a higher mortality risk.<sup><xref rid="R2" ref-type="bibr">2</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref></sup> A delay in antiretroviral therapy (ART) initiation also increases the risk of morbidity and mortality among children.<sup><xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R8" ref-type="bibr">8</xref></sup></p><p id="P6">Although Prevention of Mother-to-Child Transmission (PMTCT) programs have been an effective setting to identify HIV-exposed and &#x02013; infected infants, the success in finding undiagnosed children outside of PMTCT has been underwhelming.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Multiple approaches have been used to improve HIV detection among children, including Provider-Initiated Testing and Counselling (PITC), community and school-based approaches, and home-based testing.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> A systematic review of HIV testing among children and adolescents in sub-Saharan Africa found PITC approaches with the highest yield (percent of children tested identified as HIV-positive) include inpatient (12%), outpatient (7%), and family testing (3%), whereas home-based, outreach, and school-based programs have lower yield at 2.3, 0.06, and 0.1%, respectively.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Additionally, implementation of routine testing of pediatric inpatients has resulted in increased identification of children living with HIV and higher rates of subsequent ART initiation for those identified.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup></p><p id="P7">Strengthening case finding is critical to the achievement of the 90&#x02013;90&#x02013;90 targets.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Family testing, a focused PITC approach that targets a high-risk population by testing the children and partners of index patients in HIV care, may be an important approach for efficient and early case detection.<sup><xref rid="R13" ref-type="bibr">13</xref>&#x02013;<xref rid="R15" ref-type="bibr">15</xref></sup> A study in Malawi found that 81% of the children of adults living with HIV had not been tested; however, 33% of these children ended up being positive once tested, illustrating the potential for case finding through family testing.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> Recent efforts to utilize a family testing strategy have also shown positive results for identification and linkage to care.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> One study in Kenya identified 2.5 family members at risk per index patient, two-thirds of which were children, with more than 80% of children identified living with HIV successfully enrolled into care.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Despite improvements in child HIV testing uptake in Kenya, HIV identification remains a challenge. HIV testing yield among children declined nationally from 2.7% in 2015 to 0.5% in 2017, illustrating the need for more efficient testing strategies (routine program data from the U.S. President&#x02019;s Emergency Plan for AIDS Relief [PEPFAR] HIV reporting database; Data for Accountability, Transparency and Impact Monitoring [DATIM]). In this study, we examined the effectiveness of a routinely implemented family testing approach at identifying children living with HIV (0&#x02013;14 years of age) in comparison to other HIV testing approaches. Onward linkage to care and ART initiation after family testing were also assessed.</p></sec><sec id="S2"><title>Methods</title><sec id="S3"><title>Family approach</title><p id="P8">The family approach supported by Family AIDS Care and Education Services (FACES) at Ministry of Health (MOH) HIV clinics is based on the connection between index clients and their family members at risk. A &#x02018;family&#x02019; in this context is defined as an adult index client (&#x02265;15 years old and accessing HIV care), their sexual partner/s, and children under 15 years of age. The family approach is designed to identify, engage, and treat all family members and partners living with HIV; prevent new infections among family members at risk; and raise family support and awareness.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Within the health facility Comprehensive Care Center (CCC) and Maternal Child Health (MCH) departments, during HIV care enrollment and follow-up, counselors discuss the importance of family testing with the index client. &#x02018;Contacts&#x02019; refer to family members or sexual partners identified by index clients. This study is focused on contacts who were biological children (0&#x02013;14 years of age).</p><p id="P9">At enrollment, index clients&#x02019; family member information is documented in the Family Information Table (FIT) that was pioneered by FACES<sup><xref rid="R15" ref-type="bibr">15</xref></sup> and later incorporated into the MOH patient medical record (<xref rid="F1" ref-type="fig">Figure 1</xref>). The extent of disclosure between index clients and their contacts is assessed. Information is shared about the benefits and potential risks of disclosure, and the index client is guided through an assisted disclosure process (although disclosure is not mandatory). The index client can bring their contacts to the clinic for HIV testing during subsequent visits or have targeted home-based testing. Testing follows the Kenya national HIV testing algorithms using rapid HIV test kits. Once HIV testing is conducted, HIV-positive contacts are enrolled into care and assessed for ART initiation. HIV-negative contacts are linked to prevention services and scheduled for future testing. The index client is re-engaged about disclosure and contact testing if eligible contacts are not tested during subsequent clinic visits.</p></sec><sec id="S4"><title>Evaluation approach</title><p id="P10">This retrospective study assessed the effectiveness of the family testing approach that had been implemented as standard of care at all FACES-supported health facilities. Data collection was performed by review of clinical records among all adult clients newly enrolled in HIV care at 60 high-volume MOH health facilities. The facilities were chosen as a convenience sample based on feasibility across three high-burden counties in western Kenya (Kisumu, Homabay, and Migori). This included all index clients who enrolled in HIV care between May and July 2015 and were followed for a minimum of ten months through May 2016. Index clients&#x02019; and contacts&#x02019; patient medical record data were abstracted, including testing eligibility of children contacts (known positives were not eligible; those with previously negative test results were eligible if due for retesting per national guidelines), testing status, HIV identification, enrollment into care for those identified with HIV, and ART initiation for those eligible for ART according to the national guidelines at the time (ART was recommended for all children ten years and below; however, it was based on CD4 cell count and clinical staging for those above ten years; the national guidelines did not adopt WHO&#x02019;s 2015 recommendation of &#x02018;test and treat&#x02019; for all children until 2016).<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p><p id="P11">To compare the family testing approach to PITC for children in outpatient and inpatient departments, family testing data were compared to abstracted aggregate data on HIV testing and identification of children from routine MOH outpatient and inpatient reports at the same health facilities during the same enrollment period as the family testing cohort period: May 2015&#x02013;July 2015. The family testing data in the CCC and MCH were captured separately from outpatient and inpatient testing data reports to prevent overlap in approach comparison. The PITC performed in the outpatient and inpatient PITC during the study period consisted of routine testing of all patients accessing services those departments. No risk screening tools were used to determine who should receive outpatient or inpatient PITC. Abstracted aggregate data using MOH-designated facility level of testing sites: level 4 (county and sub-county hospitals), level 3 (health centers), and level 2 (dispensaries) were also compared.<sup><xref rid="R18" ref-type="bibr">18</xref></sup></p><p id="P12">Descriptive statistics were generated and Chi square test was conducted to compare the HIV testing yield between the family testing, outpatient and inpatient testing approaches. Statistical analysis was performed with STATA version 12.0 (StataCorp, College Station, TX).</p><p id="P13">This evaluation was approved by the Kenya Medical Research Institute Ethical Review Committee and University of California San Francisco Human Research Protection Program. It was also reviewed in accordance with the Centers for Disease Control and Prevention (CDC) human research protection procedures and was determined to be research, but CDC investigators did not interact with human subjects or have access to identifiable data or specimens for research purposes. Data were captured as part of routinely gathered medical information and reviewed retrospectively for program evaluation, and therefore informed consent was not obtained.</p></sec></sec><sec id="S5"><title>Results</title><p id="P14">A total of 1937 adult index clients were identified as newly enrolled in care at the 60 study sites resulting in identification of 3005 children as contacts. Among child contacts, 2848 (94.8%) were tested for HIV through the family testing approach and 127 (4.5%) were HIV-positive. Applying the positivity rate of 4.5% for the entire cohort at risk (including the 157 children not tested), this approach identified 94.1% of all children living with HIV in the cohort (127 children identified out of 135 children expected to be HIV-positive). Of the children with diagnosed HIV infection, 100 (78.7%) were successfully linked to HIV care. Ninety-three children were eligible to initiate ART according to the national guidelines, out of whom 85 (91.4%) were initiated on ART during the study period.</p><p id="P15">At the same 60 study sites, 27,402 children were tested through PITC in outpatient departments identifying 338 children living with HIV for a yield of 1.2%. In inpatient departments, 1459 children were tested through PITC, identifying 23 children living with HIV for a yield of 1.6% (<xref rid="T1" ref-type="table">Table 1</xref>). Family testing had higher yield (p &#x0003c; 0.001) compared to testing in both outpatient and inpatient departments and was consistent across all health facility levels (<xref rid="T1" ref-type="table">Table 1</xref>).</p></sec><sec id="S6"><title>Discussion</title><p id="P16">The family testing approach using index clients newly enrolled in care resulted in high HIV identification yield among children (4.5%), comparable to other studies evaluating the efficacy of utilizing index patients to increase HIV case finding in children.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> In the study by Ahmed et al.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> assessing a similar model for identification and linkage to care in Malawi, 64.7% of HIV-positive index patients who agreed to testing of household members had an untested child or young person at home, of which 4.0% were found to be living with HIV. In the study by Yumo et al.,<sup><xref rid="R20" ref-type="bibr">20</xref></sup> when parents living with HIV in Cameroon were invited to have their children tested for HIV, they found a 3.5% HIV identification yield. A study in Kenya by Wagner et al.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> demonstrated 42% of patients living with HIV with children had an untested child, with an HIV prevalence of 7.4% among those children once tested. The higher HIV identification yield found by Wagner et al. could be explained by several factors: their data were collected two years earlier than ours, and there is a general temporal decrease in testing yield as the population of children with unknown HIV status decreases; their study population was drawn for people accessing services at the national referral hospital in Nairobi, compared to our study sites in urban, periurban, and rural areas, and their study population was younger (&#x02264;12 years, compared to our study population of &#x02264;14 years).</p><p id="P17">This study found that the HIV case identification rate for children using the family testing strategy with newly enrolled index clients was almost four-fold greater than outpatient testing and almost three-fold greater than inpatient testing strategies among children. Yumo et al.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> also found a higher testing yield among children tested through index parents compared to outpatient testing (3.5% and 1.6%, respectively), although this was only a two-fold difference compared to the almost four-fold difference in our study. These comparisons at the same health facilities during the same periods are unique and provide a more valid comparison between strategies, accounting for temporal and geographic differences in HIV trends. Although several studies found high HIV case identification rates among outpatient clinics and inpatient wards,<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup> more recent studies corroborate our finding of decreased yield in pediatric outpatient clinics and inpatient wards. A study in Malawi found an HIV yield of only 1.0%, among children newly tested within inpatient wards,<sup><xref rid="R23" ref-type="bibr">23</xref></sup> and another study across six African countries identified a reduction in HIV yield among children in just a year&#x02019;s time, from 2.2% in 2015 to 0.9% in 2016.<sup><xref rid="R24" ref-type="bibr">24</xref></sup> National data show a decline in HIV positivity among children tested in Kenya from 2.7% in 2015 to 0.5% in 2017 (routine program data from DATIM).</p><p id="P18">It is important to note that although the HIV case identification rate was significantly higher with the family testing strategy, the absolute number of children living with HIV identified was higher with universal outpatient testing. Family testing, outpatient testing, and inpatient testing contribution to the total case load of children living with HIV identified was 26%, 69%, and 5%, respectively. This indicates that despite a lower yield, outpatient testing is still an important strategy for identifying children living with HIV. Systems that better identify HIV exposure risk among children in outpatient settings may allow for more efficient targeted testing.</p><p id="P19">Despite many known caregiver barriers to HIV testing of children, related to fear and stigma, denial, and structural barriers, such as transportation to the clinic,<sup><xref rid="R25" ref-type="bibr">25</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref></sup> we found a very high uptake of testing children (94.8%) using the family approach. In comparison, studies in Malawi and Cameroon only achieved uptakes of 62.6% and 56.7%, respectively.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> The high testing uptake we achieved could be due to several reasons: targeted and longitudinal follow-up with index parents and eligible contacts, where a healthcare worker was prompted by the FIT in the index parent&#x02019;s chart, as a reminder to ask about any remaining untested children at every visit; home-based testing options, where an index parent could opt to having a healthcare worker visit their home to conduct the HIV testing for their children instead incurring the extra costs and inconvenience of bringing their children to the health facility for testing; and the patient&#x02013;provider relationship established with the index client as they receive their HIV care and ART over time, allowing for the establishment of trust and for multiple opportunities to discuss the importance of child testing. No incentives were provided to parents to have their children tested.</p><p id="P20">The family testing approach resulted in identification of 94.1% of the children expected to be positive in the cohort, surpassing the first &#x0201c;90&#x0201d; in the 90&#x02013;90&#x02013;90 targets. However, linkage to care was only 78.7%. ART initiation was 91.4% of the linked patients who were eligible for ART. Based on other studies, the family approach may boost linkage over routine approaches; a program in Lesotho using family testing found 90% linkage among children identified with HIV whereas a retrospective review of baseline routine testing and linkage among children in Uganda reported 58% linkage.<sup><xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup> The ART initiation findings in our study are corroborated by previous studies using the family approach, in which ART was initiated in over 85% of children living with HIV.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup></p><p id="P21">This study had several limitations to consider. This study was conducted in an HIV high-burden region of Kenya that may have different societal stressors and cultural norms related to HIV testing and treatment compared to other countries. Therefore, our results may not be generalizable to other populations. There may also be a degree of participation bias, as the clinics participating in the study were selected as a convenience sample. Data on linkage and ART initiation were collected only for the family testing strategy, so a direct comparison with linkage and ART initiation with outpatient and inpatient HIV testing strategies could not be made.</p></sec><sec id="S7"><title>Conclusion</title><p id="P22">The family HIV testing approach resulted in a high HIV identification yield for children and demonstrates promise in achieving the first two &#x0201c;90s&#x0201d; of the 90&#x02013;90&#x02013;90 targets for children, with additional efforts required to improve linkage. Implementing family testing in populations with similar epidemics may help to increase diagnosis of children living with HIV. Despite the decreasing and relatively low yield for inpatient and outpatient testing approaches, outpatient testing still provided the highest contribution to children living with HIV identified. More efficient models of finding undiagnosed children in outpatient and inpatient settings should be explored.</p></sec></body><back><ack id="S8"><title>Acknowledgements</title><p id="P23">The authors would like to thank the health facility staff and FACES team in Kenya for their guidance, wisdom, and assistance with carrying out this project. We would also like to gratefully acknowledge the Director of KEMRI, the Director of KEMRI&#x02019;s Centre for Microbiology Research, and the Kisumu County Ministry of Health for their support. The findings and conclusions are those of the authors and do not necessarily represent the official position of the funding agencies.</p><p id="P24">Funding</p><p id="P25">The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the U.S. PEPFAR through the CDC under the terms of NU2GGH001947.</p></ack><fn-group><fn fn-type="COI-statement" id="FN2"><p id="P26">Declaration of conflicting interests</p><p id="P27">The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="web"><collab>UNAIDS</collab>. <source>AIDSinfo database</source>, <comment><ext-link ext-link-type="uri" xlink:href="https://aidsinfo.unaids.org">https://aidsinfo.unaids.org</ext-link></comment> (<year>2018</year>, <comment>accessed</comment>
<date-in-citation>15 August 2019</date-in-citation>).</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Ng&#x02019;eno</surname><given-names>B</given-names></name>, <name><surname>Mwangi</surname><given-names>A</given-names></name>, <name><surname>Ng&#x02019;ang&#x02019;a</surname><given-names>L</given-names></name>, <etal/>
<article-title>Burden of HIV infection among children aged 18 months to 14 years in Kenya: results from a nationally representative population-based cross-sectional survey</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2014</year>; <volume>66</volume>: <fpage>S82</fpage>&#x02013;<lpage>S88</lpage>.<pub-id pub-id-type="pmid">24732823</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>S</given-names></name>, <name><surname>Kim</surname><given-names>MH</given-names></name>, <name><surname>Sugandhi</surname><given-names>N</given-names></name>, <etal/>
<article-title>Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children</article-title>. <source>AIDS</source>
<year>2013</year>; <volume>27</volume>: <fpage>S235</fpage>&#x02013;<lpage>S245</lpage>.<pub-id pub-id-type="pmid">24361633</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Horwood</surname><given-names>C</given-names></name>, <name><surname>Butler</surname><given-names>LM</given-names></name>, <name><surname>Vermaak</surname><given-names>K</given-names></name>, <etal/>
<article-title>Disease profile of children under 5 years attending primary health care clinics in a high HIV prevalence setting in South Africa</article-title>. <source>Trop Med Int Health</source>
<year>2011</year>; <volume>16</volume>: <fpage>42</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">21091856</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Charlebois</surname><given-names>ED</given-names></name>, <name><surname>Ruel</surname><given-names>TD</given-names></name>, <name><surname>Gasasira</surname><given-names>AF</given-names></name>, <etal/>
<article-title>A short-term risk of HIV-disease progression and death in Ugandan children not eligible for antiretroviral therapy</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2010</year>; <volume>55</volume>: <fpage>330</fpage>&#x02013;<lpage>335</lpage>.<pub-id pub-id-type="pmid">20592617</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Crowell</surname><given-names>CS</given-names></name>, <name><surname>Huo</surname><given-names>Y</given-names></name>, <name><surname>Tassiopoulos</surname><given-names>K</given-names></name>, <etal/>
<article-title>Early viral suppression improves neurocognitive outcomes in HIV-infected children</article-title>. <source>AIDS</source>
<year>2015</year>; <volume>29</volume>: <fpage>295</fpage>&#x02013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">25686678</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Luzuriaga</surname><given-names>K</given-names></name>, <name><surname>Tabak</surname><given-names>B</given-names></name>, <name><surname>Garber</surname><given-names>M</given-names></name>, <etal/>
<article-title>HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment</article-title>. <source>J Infect Dis</source>
<year>2014</year>; <volume>210</volume>: <fpage>1529</fpage>&#x02013;<lpage>1538</lpage>.<pub-id pub-id-type="pmid">24850788</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Shiau</surname><given-names>S</given-names></name>, <name><surname>Arpadi</surname><given-names>S</given-names></name>, <name><surname>Strehlau</surname><given-names>R</given-names></name>, <etal/>
<article-title>Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus</article-title>. <source>J Pediatr</source>
<year>2013</year>; <volume>162</volume>: <fpage>1138</fpage>&#x02013;<lpage>1145</lpage>: <fpage>e11452</fpage>.<pub-id pub-id-type="pmid">23312691</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Govindasamy</surname><given-names>D</given-names></name>, <name><surname>Ferrand</surname><given-names>RA</given-names></name>, <name><surname>Wilmore</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Uptake and yield of HIV testing and counselling among children and adolescents in sub-Saharan Africa: a systematic review</article-title>. <source>J Int AIDS Soc</source>
<year>2015</year>; <volume>18</volume>: <fpage>20182</fpage>.<pub-id pub-id-type="pmid">26471265</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>McCollum</surname><given-names>ED</given-names></name>, <name><surname>Preidis</surname><given-names>GA</given-names></name>, <name><surname>Kabue</surname><given-names>MM</given-names></name>, <etal/>
<article-title>Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study</article-title>. <source>PLoS ONE</source>
<year>2010</year>; <volume>5</volume>: <fpage>e9626</fpage>.<pub-id pub-id-type="pmid">20224782</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Mccollum</surname><given-names>ED</given-names></name>, <name><surname>Preidis</surname><given-names>GA</given-names></name>, <name><surname>Golitko</surname><given-names>CL</given-names></name>, <etal/>
<article-title>Routine inpatient HIV testing system increases access to pediatric HIV care in sub-Saharan Africa</article-title>. <source>Pediatr Infect Dis J</source>
<year>2011</year>; <volume>30</volume>: <fpage>e75</fpage>&#x02013;<lpage>e81</lpage>.<pub-id pub-id-type="pmid">21297520</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="book"><collab>UNAIDS</collab>. <source>90&#x02013;90&#x02013;90 &#x02013; an ambitious treatment target to help end the AIDS epidemic</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>UNAIDS</publisher-name>, <comment><ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2017/90-90-90">https://www.unaids.org/en/resources/documents/2017/90-90-90</ext-link></comment> (<year>2017</year>, <comment>accessed</comment>
<date-in-citation>1 August 2019</date-in-citation>).</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>D</given-names></name>, <name><surname>Lungu</surname><given-names>M</given-names></name> and <name><surname>Van Oosterhout</surname><given-names>JJ</given-names></name>. <article-title>HIV testing coverage of family members of adult antiretroviral therapy patients in Malawi</article-title>. <source>AIDS Care</source>
<year>2010</year>; <volume>22</volume>: <fpage>1346</fpage>&#x02013;<lpage>1349</lpage>.<pub-id pub-id-type="pmid">20635242</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Kellerman</surname><given-names>S</given-names></name> and <name><surname>Essajee</surname><given-names>S</given-names></name>. <article-title>HIV testing for children in resource-limited settings: what are we waiting for?</article-title>
<source>PLoS Med</source>
<year>2010</year>; <volume>7</volume>: <fpage>e1000285</fpage>.<pub-id pub-id-type="pmid">20652012</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Lewis Kulzer</surname><given-names>J</given-names></name>, <name><surname>Penner</surname><given-names>JA</given-names></name>, <name><surname>Marima</surname><given-names>R</given-names></name>, <etal/>
<article-title>Family model of HIV care and treatment: a retrospective study in Kenya</article-title>. <source>J Int AIDS Soc</source>
<year>2012</year>; <volume>15</volume>: <fpage>8</fpage>.<pub-id pub-id-type="pmid">22353553</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Meyer</surname><given-names>M</given-names></name>, <name><surname>Elmer-DeWitt</surname><given-names>M</given-names></name>, <name><surname>Blat</surname><given-names>C</given-names></name>, <etal/>
<article-title>Evaluation and utility of a family information table to identify and test children at risk for HIV in Kenya</article-title>. <source>Int J MCHAIDS</source>
<year>2014</year>; <volume>2</volume>: <fpage>236</fpage>&#x02013;<lpage>243</lpage>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="book"><collab>Ministry of Health, National AIDS and STI Control Program (NASCOP)</collab>. <source>Guidelines on use of antiretroviral drugs for treating and preventing HIV infection: a rapid advice</source>, <publisher-name>NASCOP</publisher-name>, <publisher-loc>Nairobi, Kenya</publisher-loc>, <year>2014</year>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="web"><collab>National Coordinating Agency for Population and Development Kenya (NCAPD), Ministry of Health (MOH), Central Bureau of Statistics (CBS), ORC Macro</collab>. <source>Kenya service assessment survey 2004. Chapter 2 Overview of Kenya Health Care System</source>, <comment><ext-link ext-link-type="uri" xlink:href="https://dhsprogram.com/pubs/pdf/SPA8/SPA8.pdf">https://dhsprogram.com/pubs/pdf/SPA8/SPA8.pdf</ext-link></comment> (<year>2005</year>, <comment>accessed</comment>
<date-in-citation>20 July 2019</date-in-citation>).</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>S</given-names></name>, <name><surname>Sabelli</surname><given-names>RA</given-names></name>, <name><surname>Simon</surname><given-names>K</given-names></name>, <etal/>
<article-title>Index case finding facilitates identification and linkage to care of children and young persons living with HIV/AIDS in Malawi</article-title>. <source>Trop Med Int Health</source>
<year>2017</year>; <volume>22</volume>: <fpage>1021</fpage>&#x02013;<lpage>1029</lpage>.<pub-id pub-id-type="pmid">28544728</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Yumo</surname><given-names>HH</given-names></name>, <name><surname>Kuaban</surname><given-names>C</given-names></name>, <name><surname>Ajeh</surname><given-names>RA</given-names></name>, <etal/>
<article-title>Active case finding: comparison of the acceptability, feasibility and effectiveness of targeted versus blanket provider-initiated testing</article-title>. <source>BMC Pediatr</source>
<year>2018</year>; <volume>18</volume>: <fpage>309</fpage>.<pub-id pub-id-type="pmid">30253758</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Wagner</surname><given-names>AD</given-names></name>, <name><surname>Mugo</surname><given-names>C</given-names></name>, <name><surname>Njuguna</surname><given-names>IN</given-names></name>, <etal/>
<article-title>Active referral of children of HIV-positive adults reveals high prevalence of undiagnosed HIV</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2016</year>; <volume>73</volume>: <fpage>e83</fpage>&#x02013;<lpage>e89</lpage>.<pub-id pub-id-type="pmid">27846074</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Esamai</surname><given-names>F</given-names></name> and <name><surname>Buku</surname><given-names>GM</given-names></name>. <article-title>HIV seropositivity in children admitted with diarrhoea at Eldoret District Hospital</article-title>. <source>East Afr Med J</source>
<year>1994</year>; <volume>71</volume>: <fpage>631</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">7821240</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="confproc"><name><surname>Simon</surname><given-names>K</given-names></name>, <name><surname>Montandon</surname><given-names>M</given-names></name>, <name><surname>Ahmed</surname><given-names>S</given-names></name>, <etal/>
<article-title>Provider-initiated testing and counseling: is it still high yield? Yield of routine HIV testing in pediatric and adult inpatient wards in central and southern Malawi</article-title>. In: <conf-name>The 9th international AIDS conference</conf-name>, <conf-loc>Paris, France</conf-loc>, <conf-date>23&#x02013;26 July 2017</conf-date>, <comment>abstract no. TUPED1222.</comment></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="confproc"><name><surname>Wolters</surname><given-names>T</given-names></name>, <name><surname>Okoth</surname><given-names>E</given-names></name>, <name><surname>Ahimbisibwe</surname><given-names>A</given-names></name>, <etal/>
<article-title>Trends in pediatric HIV testing across six African countries</article-title>. In: <conf-name>The 9th international AIDS conference</conf-name>, <conf-loc>Paris, France</conf-loc>, <conf-date>23&#x02013;26 July 2017</conf-date>, <comment>abstract no. WEAD0101.</comment></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Bahwere</surname><given-names>P</given-names></name>, <name><surname>Piwoz</surname><given-names>E</given-names></name>, <name><surname>Joshua</surname><given-names>MC</given-names></name>, <etal/>
<article-title>Uptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive study</article-title>. <source>BMC Infect Dis</source>
<year>2008</year>; <volume>8</volume>: <fpage>106</fpage>.<pub-id pub-id-type="pmid">18671876</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Bandason</surname><given-names>T</given-names></name>, <name><surname>Langhaug</surname><given-names>LF</given-names></name>, <name><surname>Makamba</surname><given-names>M</given-names></name>, <etal/>
<article-title>Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: a mixed methods study</article-title>. <source>AIDS Care</source>
<year>2013</year>; <volume>25</volume>: <fpage>1520</fpage>&#x02013;<lpage>1526</lpage>.<pub-id pub-id-type="pmid">23528004</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Davies</surname><given-names>MA</given-names></name> and <name><surname>Pinto</surname><given-names>J</given-names></name>. <article-title>Targeting 90&#x02013;90&#x02013;90 &#x02013; don&#x02019;t leave children and adolescents behind</article-title>. <source>J Int AIDS Soc</source>
<year>2015</year>; <volume>18</volume>: <fpage>20745</fpage>.<pub-id pub-id-type="pmid">26639121</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Donahue</surname><given-names>MC</given-names></name>, <name><surname>Dube</surname><given-names>Q</given-names></name>, <name><surname>Dow</surname><given-names>A</given-names></name>, <etal/>
<article-title>&#x0201c;They have already thrown away their chicken&#x0201d;: barriers affecting participation by HIV-infected women in care and treatment programs for their infants in Blantyre, Malawi</article-title>. <source>AIDS Care</source>
<year>2012</year>; <volume>24</volume>: <fpage>1233</fpage>&#x02013;<lpage>1239</lpage>.<pub-id pub-id-type="pmid">22348314</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Vreeman</surname><given-names>RC</given-names></name>, <name><surname>Nyandiko</surname><given-names>WM</given-names></name>, <name><surname>Braitstein</surname><given-names>P</given-names></name>, <etal/>
<article-title>Acceptance of HIV testing for children ages 18 months to 13 years identified through voluntary, home-based HIV counseling and testing in western Kenya</article-title>. <source>J Acquir Immune Defic Syndr</source>
<year>2010</year>; <volume>55</volume>: <fpage>e3</fpage>&#x02013;<lpage>e10</lpage>.<pub-id pub-id-type="pmid">20714272</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Boeke</surname><given-names>C</given-names></name>, <name><surname>Nabitaka</surname><given-names>V</given-names></name>, <name><surname>Rowan</surname><given-names>A</given-names></name>, <etal/>
<article-title>Assessing linkage to and retention in care among HIV patients in Uganda and identifying opportunities for health systems strengthening: a descriptive study</article-title>. <source>BMC Infect Dis</source>
<year>2018</year>; <volume>18</volume>: <fpage>138</fpage>.<pub-id pub-id-type="pmid">29566666</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="web"><collab>Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)</collab>. <source>Accelerating children&#x02019;s HIV/AIDS treatment: promising practices and lessons learned from implementation of the ACT initiative</source>, <comment><ext-link ext-link-type="uri" xlink:href="https://www.pedaids.org/resource/accelerating-childrens-hivaids-treatment-promising-practices-and-lessons-learned-from-the-act-initiative">https://www.pedaids.org/resource/accelerating-childrens-hivaids-treatment-promising-practices-and-lessons-learned-from-the-act-initiative</ext-link></comment> (<year>2017</year>, <comment>accessed</comment>
<date-in-citation>10 December 2019</date-in-citation>).</mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p id="P28">Family Information Table (FIT) from the Kenya Ministry of Health Patient Medical Record &#x02018;Blue Card&#x02019;.</p></caption><graphic xlink:href="nihms-1619730-f0001"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1.</label><caption><p id="P29">HIV testing yield (proportion of children who tested positive) using three different testing approaches in a retrospective study in Kenya, May&#x02013;July 2015.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="8" align="left" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Testing approach and yield</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Provider-initiated family testing</th><th colspan="2" align="left" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Provider-initiated outpatient testing</th><th colspan="2" align="left" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Provider-initiated inpatient testing</th><th colspan="2" align="left" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Total tested</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Facility (N)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Tested<break/>(N)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HIV-positive<break/>N (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Tested<break/>(N)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HIV-positive<break/>N (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Tested<break/>(N)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HIV-positive<break/>N (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Tested<break/>(N)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HIV-positive<break/>N (%)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Level 2 facilities (dispensaries) (50)</td><td align="left" valign="top" rowspan="1" colspan="1">1305</td><td align="center" valign="top" rowspan="1" colspan="1">61 (4.6)</td><td align="left" valign="top" rowspan="1" colspan="1">15,231</td><td align="center" valign="top" rowspan="1" colspan="1">158 (1.0)</td><td align="left" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="top" rowspan="1" colspan="1">16,611</td><td align="center" valign="top" rowspan="1" colspan="1">219 (1.3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Level 3 facilities (health centers) (6)</td><td align="left" valign="top" rowspan="1" colspan="1">288</td><td align="center" valign="top" rowspan="1" colspan="1">19 (6.6)</td><td align="left" valign="top" rowspan="1" colspan="1">4369</td><td align="center" valign="top" rowspan="1" colspan="1">62 (1.4)</td><td align="left" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td><td align="left" valign="top" rowspan="1" colspan="1">4707</td><td align="center" valign="top" rowspan="1" colspan="1">81 (1.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Level 4 facilities (county and sub-county hospitals) (4)</td><td align="left" valign="top" rowspan="1" colspan="1">1255</td><td align="center" valign="top" rowspan="1" colspan="1">47 (3.7)</td><td align="left" valign="top" rowspan="1" colspan="1">7802</td><td align="center" valign="top" rowspan="1" colspan="1">118 (1.5)</td><td align="left" valign="top" rowspan="1" colspan="1">1334</td><td align="center" valign="top" rowspan="1" colspan="1">23 (1.7)</td><td align="left" valign="top" rowspan="1" colspan="1">10,391</td><td align="center" valign="top" rowspan="1" colspan="1">188 (1.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">All levels (60)</td><td align="left" valign="top" rowspan="1" colspan="1">2848</td><td align="center" valign="top" rowspan="1" colspan="1">127 (4.5)</td><td align="left" valign="top" rowspan="1" colspan="1">27,402</td><td align="center" valign="top" rowspan="1" colspan="1">338 (1.2)</td><td align="left" valign="top" rowspan="1" colspan="1">1459</td><td align="center" valign="top" rowspan="1" colspan="1">23 (1.6)</td><td align="left" valign="top" rowspan="1" colspan="1">31,709</td><td align="center" valign="top" rowspan="1" colspan="1">488 (1.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chi square test</td><td colspan="8" align="left" valign="top" rowspan="1">Family testing yield to inpatient and outpatient testing yield: p&#x0003c;0.001</td></tr></tbody></table></table-wrap></floats-group></article>